Publications by authors named "Anna Pelander"

Claim this Profile
P
Post-Mortem Identification and Toxicological Findings of Fluetonitazepyne and Isotonitazepyne.
Pirkko Kriikku, Anna Pelander, Antti Jylhä, Ilkka Ojanperä

Drug Test Anal· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrochemical Point-of-Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs.
Johanna K Kujala, Terhi J Lohela, Niklas Wester, Elsi Verrinder, Anna Pelander

Basic Clin Pharmacol Toxicol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From trash to results: shortcomings and benefits of paraphernalia-based drug checking in Finland.
Teemu Kaskela, Janne Nahkuri, Aino Kankaanpää, Anna Pelander, Teemu Gunnar

Harm Reduct J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UHPLC-QTOFMS Urine Drug Screening With Dilute-and-Shoot Sample Preparation and Vacuum-Insulated Probe-Heated Electrospray Ionization.
Mira Sundström, Pirkko Kriikku, Ilkka Ojanperä, Carsten Baessmann, Anna Pelander

Drug Test Anal· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Estimation of 38 Illicit Psychostimulants in Blood by GC-APCI-QTOFMS with Nitrogen Chemiluminescence Detection Based on Three External Calibrators.
Samuel Mesihää, Ilpo Rasanen, Anna Pelander, Ilkka Ojanperä

J Anal Toxicol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data.
Pirkko Kriikku, Anna Pelander, Ilpo Rasanen, Ilkka Ojanperä

Forensic Sci Int· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS.
Mira Sundström, Anna Pelander, Ilkka Ojanperä

J Anal Toxicol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a GC-APCI-QTOFMS library for new psychoactive substances and comparison to a commercial ESI library.
Samuel Mesihää, Raimo A Ketola, Anna Pelander, Ilpo Rasanen, Ilkka Ojanperä

Anal Bioanal Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous identification and quantification of new psychoactive substances in blood by GC-APCI-QTOFMS coupled to nitrogen chemiluminescence detection without authentic reference standards.
Ilkka Ojanperä, Samuel Mesihää, Ilpo Rasanen, Anna Pelander, Raimo A Ketola

Anal Bioanal Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS.
Mira Sundström, Anna Pelander, Kaarlo Simojoki, Ilkka Ojanperä

Drug Test Anal· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
Pertti Heikman, Mira Sundström, Anna Pelander, Ilkka Ojanperä

Hum Psychopharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells.
Bjørnar den Hollander, Mira Sundström, Anna Pelander, Antti Siltanen, Ilkka Ojanperä

Sci Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
Mira Sundström, Anna Pelander, Ilkka Ojanperä

Drug Test Anal· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro-in vivo correlation of metabolic profiles and development of LC-TOF-MS method.
Masaki Kobayashi, Anna Pelander, Raimo A Ketola, Antti Leinonen, Tiia Kuuranne

Drug Test Anal· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone.
Bjørnar den Hollander, Mira Sundström, Anna Pelander, Ilkka Ojanperä, Eero Mervaala

Toxicol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of serial killing by poisoning.
Erkki Vuori, Anna Pelander, Ilpo Rasanen, Mikko Juote, Ilkka Ojanperä

Drug Test Anal· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.
Mira Sundström, Anna Pelander, Verena Angerer, Melanie Hutter, Stefan Kneisel

Anal Bioanal Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Elli Tyrkkö, Anna Pelander, Raimo A Ketola, Ilkka Ojanperä

Anal Bioanal Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
Ilkka Ojanperä, Marjo Kolmonen, Anna Pelander

Anal Bioanal Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database search.
Ana de Castro, Merja Gergov, Pekka Ostman, Ilkka Ojanperä, Anna Pelander

Anal Bioanal Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of liquid chromatographic retention for differentiation of structural isomers.
Elli Tyrkkö, Anna Pelander, Ilkka Ojanperä

Anal Chim Acta· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine, alcohol, and drug findings in young adults in a population-based postmortem database.
Terhi Launiainen, Ulla Broms, Kaisu Keskitalo-Vuokko, Janne Pitkäniemi, Anna Pelander

Nicotine Tob Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific screening method for dextran and hydroxyethyl starch in human urine by size exclusion chromatography-in-source collision-induced dissociation-time-of-flight mass spectrometry.
Marjo Kolmonen, Antti Leinonen, Tiia Kuuranne, Anna Pelander, Koen Deventer

Anal Bioanal Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a high resolving power time-of-flight mass spectrometer for drug analysis in terms of resolving power and acquisition rate.
Anna Pelander, Petra Decker, Carsten Baessmann, Ilkka Ojanperä

J Am Soc Mass Spectrom· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis